M&A Deal Summary

OrthoPediatrics Acquires Boston Orthotics & Prosthetics

On January 8, 2024, OrthoPediatrics acquired medical products company Boston Orthotics & Prosthetics for 22M USD

Acquisition Highlights
  • This is OrthoPediatrics’ 4th transaction in the Medical Products sector.
  • This is OrthoPediatrics’ largest (disclosed) transaction.
  • This is OrthoPediatrics’ 2nd transaction in the United States.
  • This is OrthoPediatrics’ 1st transaction in Massachusetts.

M&A Deal Summary
Date 2024-01-08
Target Boston Orthotics & Prosthetics
Sector Medical Products
Buyer(s) OrthoPediatrics
Deal Type Add-on Acquisition
Deal Value 22M USD

Target

Boston Orthotics & Prosthetics

Avon, Massachusetts, United States
Boston Orthotics & Prosthetics is a pediatric orthotics company that provides non-surgical scoliosis treatment options. The company has been dedicated to advancing the specialized orthotics and prosthetics profession with educational support, training, and cutting-edge technology and treatment techniques for managing scoliosis, plagiocephaly, and various neuromuscular disorders. Boston Orthotics & Prosthetics is based in Avon, Massachusetts.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

OrthoPediatrics

Warsaw, Indiana, United States
Category Company
Founded 2007
Sector Medical Products
DESCRIPTION

OrthoPediatrics is the first company whose total focus is helping children with orthopaedic conditions and injuries by providing the surgeons who care for them with anatomically appropriate implants. Children’s bones have anatomical differences such as growth plates that must be protected and curvatures that are greater than in adults. In the past, surgeons have had to modify implants that were primarily designed for adults in an effort to make them work in children.

DEAL STATS #
Overall 4 of 4
Sector (Medical Products) 4 of 4
Type (Add-on Acquisition) 3 of 3
State (Massachusetts) 1 of 1
Country (United States) 2 of 2
Year (2024) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-06-14 Pega Medical

Laval, Quebec, Canada

Pega Medical is a bioengineering services company focused on key innovations within the trauma and deformity patient population, including developing the Fassier-Duval Telescopic IM System, an innovative implant designed to treat bony deformities in children with osteogenesis imperfecta without disrupting their normal growth. Pega Medical was founded in 1994 and is based in Laval, Quebec.

Buy -
Mergr

Product

Company

Legal